Suchergebnisse - (Subject:"angiotensin-converting enzyme inhibitors")

PubPharm (319)

11

COVID-19 and hypertension : risks and management. A scientific statement on behalf of the British and Irish Hypertension Society

enthalten in: Journal of human hypertension | 2021

von Clark, C. | McDonagh, S. | McManus, R. | +1

12

Managing hypertension during the COVID-19 pandemic

enthalten in: Journal of human hypertension | 2020

von Nadar, S. | Tayebjee, M. | Stowasser, M. | +1

CommentIn: J Hum Hypertens. 2021 May;35(5):387-388. - PMID 33303952

13

The association of antihypertensive use and depressive symptoms in a large older population with hypertension living in Australia and the United States : a cross-sectional study

enthalten in: Journal of human hypertension | 2020

von Agustini, B. | Mohebbi, M. | Woods, R. | +10

14

A systematic review and network meta-analysis of the comparative efficacy of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension

enthalten in: Journal of human hypertension | 2019

von Dimou, C. | Antza, C. | Akrivos, E. | +4

15

First-line renin-angiotensin system inhibitors vs. other first-line antihypertensive drug classes in hypertensive patients with type 2 diabetes mellitus

enthalten in: Journal of human hypertension | 2018

von Wang, G. | Chen, Y. | Li, L. | +2

16

Preventive effect of renin-angiotensin system inhibitors on new-onset atrial fibrillation in hypertensive patients : a propensity score matching analysis

enthalten in: Journal of human hypertension | 2017

von Horio, T. | Akiyama, M. | Iwashima, Y. | +9

CommentIn: J Hum Hypertens. 2017 Jul;31(7):425-426. - PMID 28588316

17

Renin-angiotensin blockade in atrial fibrillation : where are we now?

enthalten in: Journal of human hypertension | 2017

von Shahid, F. | Lip, G. | Shantsila, E.

CommentOn: J Hum Hypertens. 2017 Jul;31(7):450-456. - PMID 28032630

18

Risk of acute myocardial infarction after discontinuation of antihypertensive agents: a case-control study

enthalten in: Journal of human hypertension | 2017

von F F Alharbi | P C Souverein | M C De Groot | +3

19

Impact of ACE2 gene polymorphism on antihypertensive efficacy of ACE inhibitors

enthalten in: Journal of human hypertension | 2016

von Chen, Y. | Liu, D. | Zhang, P. | +8

20

Positive effects of aggressive vasodilator treatment of well-treated essential hypertensive patients

enthalten in: Journal of human hypertension | 2016

von Engholm, M. | Mulvany, M. | Eftekhari, A. | +3